No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression
The aim of the study was to assess regional control and survival in primary irradiated oropharyngeal cancer patients with advanced neck disease (≥cN2a) receiving planned neck dissection (PND) irrespective of the nodal response compared to salvage neck dissection (SND) in case of regional persistence or reccurence in relation to tumoral p16 overexpression. 96 consecutive patients treated at the University Hospital of Zurich, Switzerland were included. Tissue microarray-based scoring of p16 expression was obtained. 5 years overall (OS) and disease-specific survival (DSS) in the PND and SND cohort were 70 vs. 57 % (p = 0.20) and 80 vs. 65 % (p = 0.14), respectively. Regional control in PND and SND achieved 95 vs. 87 % (p = 0.29), respectively. There was no statistically significant impact of neck treatment (PND vs. SND) on regional control or survival among patients with p16-negative tumors (5 years OS 59 vs. 50 %, p = 0.66; 5 years DSS 59 vs. 57 %, p = 0.89) nor among patients with p16-positive tumors (5 years OS 84 vs. 67 %, p = 0.21; 5 years DSS 95 vs. 81 %, p = 0.24). The type of neck dissection after primary intensity-modulated radiotherapy (IMRT) had no impact on regional control and survival even in human papillomavirus (HPV)-associated disease. Therefore we are convinced that based on the accuracy of newer diagnostic modalities the surveillance of a radiologically negative neck after primary chemoradiation (CRT) is oncologically safe irrespective of p16 expression of the tumor.
KeywordsOropharyngeal squamous cell carcinoma Planned neck dissection Salvage neck dissection p16 expression Regional tumor control Survival
Conflict of interest
The authors declare that they have no conflict of interest.
The study protocol obtained approval by the local Ethics Committee and all procedures were in accordance with the ethical standards of the Helsinki Declaration of 1975, as revised in 1983. For this retrospective data analysis formal consent was not required.
- 6.Pellini R, Manciocco V, Turri-Zanoni M, Vidiri A, Sanguineti G, Marucci L et al (2014) Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease. J Craniomaxillofac Surg 42(8):1834–1839CrossRefPubMedGoogle Scholar
- 8.Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R et al (2009) Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 50(1):24–29CrossRefPubMedGoogle Scholar
- 23.Broglie MA, Soltermann A, Rohrbach D, Haile SR, Pawlita M, Studer G et al (2013) Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head Neck 35(12):1698–1706CrossRefPubMedGoogle Scholar
- 39.Simon C, Goepfert H, Rosenthal DI, Roberts D, El-Naggar A, Old M et al (2006) Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol 263(4):313–318CrossRefPubMedGoogle Scholar
- 55.Shonka DC Jr, Shoushtari AN, Thomas CY, Moskaluk C, Read PW, Reibel JF et al (2009) Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status. Arch Otolaryngol Head Neck Surg 135(11):1126–1132CrossRefPubMedGoogle Scholar